Vulvovaginal candidiasis from non-albicans species: Retrospective study of recurrence rate after fluconazole therapy

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 6, 2006, Pages 475-478

  Ventolini, Gary ^a   Baggish, Michael S ^a   Walsh, Peggy M ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Candida albicans; Candidiasis, vulvovaginal; Fluconazole

Indexed keywords

FLUCONAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA STELLOIDEA; CANDIDA TROPICALIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; GROUPS BY AGE; HUMAN; HYGIENE; MAJOR CLINICAL STUDY; NULLIPARA; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VAGINA CANDIDIASIS;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; FLUCONAZOLE; HUMANS; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 33745189839     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sobel JD: Vulvovaginitis due to Candida glabrata: An emerging problem. Mycoses (suppl 2) 1998;41:18-22
2. Bellitti F, Cuniato V, Nocera E, et al: Candidal vulvovaginitis: An epidemiological survey among Italian prostitutes. Infez Med 2002;10:31-36
3. Corsello S, Spinillo A, Osnengo G, et al: An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 2003;110:66-72
4. Sobel JD: Antimicrobial resistance in vulvovaginitis. Curr Infect Dis Rep 2001;3:546-549
5. Sojakova M, Liptajova D, Borovsky M, et al: Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 2004;157:163-169
6. MacNeill C, Carey JC: Recurrent vulvovaginal candidiasis. Curr Womens Health Rep 2001;1:31-35
7. Sobel JD, Wiesenfeld HC, Martens M, et al: Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;19:153-156
8. Bennett JE, Izumikawa K, Marr KA: Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 2004;48:1773-1777
9. Al-Rawi N, Kavanagh K: Characterization of yeasts implicated in vulvovaginal candidosis in Irish women. Br J Biomed Sci 1999;56:99-104
10. Sobel JD: Treatment of vaginal candida infections. Expert Opin Pharmacother 2002;3:1059-1065
11. Cross EW, Park S, Perlin DAS: Cross-resistance of clinical isolates of candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis. Microb Drug Resist 2000;6:155-161
12. Fodor E, Dosa E, Nagy A, et al: Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis. Ada Microbial Immunol Hung 2002;49:59-68
13. Richter SS, Galask RP, Messer SA, et al: Antifungal susceptibilities of candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005;43:2155-2162
14. Patel DA, Gillispie B, Sobel JD, et al: Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: Results of a prospective cohort study. Am J Obstet Gynecol 2004;190:644-653
15. Reed BD, Zazove P, Pierson CL, et al: Candida transmission and sexual behaviors as risk for a repeat episode of candida vulvovaginitis. J Womens Health 2003;12:979-989
16. Ventolini G, Baggish MS: Post-menopausal recurrent vaginal candidiasis: Effect of hysterectomy on response to treatment of colonization and recurrence rates post-treatment. Maturitas (in press)
17. Ventolini G, Baggish MS: Recurrent fungal vulvovaginitis and its association with vaginal bacterial colonization. J Gynecol Surg 2003;19:153-156